Proxima
Proxima Bio develops programmable medicines that modulate protein interactions to address disease processes. It focuses on creating proximity-modulating therapeutics that direct protein interactions for potential use in conditions such as autoimmune disorders and cancer, expanding the range of targets that traditional drugs cannot easily reach. Proxima Bio combines structural biology, data generation, and machine learning to identify actionable protein-protein interfaces and support the discovery of new therapeutic modalities. The company works with pharmaceutical partners to apply its platform in research collaborations and advance drug discovery pipelines. Proxima Bio’s platform integrates multiple technologies to support the design and discovery of novel proximity-based treatment approaches.
Domain
proximabio.com
Country
United StatesIndustry
Alternative MedicineEmployees
11-50
Last Funding
$86.3M
Founded
2018
Tech Stack (8 technologies)
Frequently Asked Questions
What technologies does Proxima use?+
Proxima uses 8 technologies including Vercel Analytics, Next.js, React.
What industry is Proxima in?+
Proxima operates in the Alternative Medicine industry.
Where is Proxima based?+
Proxima is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026